Indianapolis pharmaceutical giant Eli Lilly announced Monday that it has begun testing a potential antibody treatment for the coronavirus. The experimental drug was developed from a blood sample of one of America’s first COVID-19 patients.
Indianapolis pharmaceutical giant Eli Lilly announced Monday that it has begun testing a potential antibody treatment for the coronavirus. The experimental drug was developed from a blood sample of one of America’s first COVID-19 patients.